Good quality white‐light transurethral resection of bladder tumours (GQ‐WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non‐muscle‐invasive bladder cancer: validation across time and place and recommendation for benchmarking
Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experie...
Saved in:
Published in | BJU international Vol. 109; no. 11; pp. 1666 - 1673 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.06.2012
Wiley-Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1464-4096 1464-410X 1464-410X |
DOI | 10.1111/j.1464-410X.2011.10571.x |
Cover
Abstract | Study Type – Therapy (cohort)
Level of Evidence 2b
What's known on the subject? and What does the study add?
Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen.
This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours.
OBJECTIVE
•
To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT.
PATIENTS AND METHODS
•
Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK.
•
Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re‐TURBT were evaluated.
•
Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five).
•
Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re‐TURBT or the first check cystoscopy.
RESULTS
•
From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis.
•
Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7–7.5, P < 0.001).
•
Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3–10.7, P < 0.001)
•
Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1–12.9, P < 0.001).
CONCLUSIONS
•
Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT.
•
Documented complete resection by experienced surgeons with DM presence (good quality white‐light TURBT) should be considered a benchmark for white‐light TURBT in NMIBC. |
---|---|
AbstractList | Study Type - Therapy (cohort) Level of Evidence2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. OBJECTIVE * To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. PATIENTS AND METHODS * Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. * Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. * Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). * Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy. RESULTS * From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. * Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). * Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) * Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001). CONCLUSIONS * Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. * Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC. [PUBLICATION ABSTRACT] Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours.UNLABELLEDStudy Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours.To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT.OBJECTIVETo validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT.Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy.PATIENTS AND METHODSPatients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy.From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001).RESULTSFrom a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001).Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. • Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC.CONCLUSIONSDetrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. • Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC. Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy. From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001). Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. • Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC. Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. OBJECTIVE • To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. PATIENTS AND METHODS • Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. • Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re‐TURBT were evaluated. • Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). • Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re‐TURBT or the first check cystoscopy. RESULTS • From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. • Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7–7.5, P < 0.001). • Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3–10.7, P < 0.001) • Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1–12.9, P < 0.001). CONCLUSIONS • Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. • Documented complete resection by experienced surgeons with DM presence (good quality white‐light TURBT) should be considered a benchmark for white‐light TURBT in NMIBC. |
Author | Mariappan, Paramananthan Finney, Steven M. Zachou, Alexandra N'Dow, James Smith, Gordon Grigor, Kenneth M. Somani, Bhaskar K. Head, Elizabeth Mishriki, Said F. |
Author_xml | – sequence: 1 givenname: Paramananthan surname: Mariappan fullname: Mariappan, Paramananthan – sequence: 2 givenname: Steven M. surname: Finney fullname: Finney, Steven M. – sequence: 3 givenname: Elizabeth surname: Head fullname: Head, Elizabeth – sequence: 4 givenname: Bhaskar K. surname: Somani fullname: Somani, Bhaskar K. – sequence: 5 givenname: Alexandra surname: Zachou fullname: Zachou, Alexandra – sequence: 6 givenname: Gordon surname: Smith fullname: Smith, Gordon – sequence: 7 givenname: Said F. surname: Mishriki fullname: Mishriki, Said F. – sequence: 8 givenname: James surname: N'Dow fullname: N'Dow, James – sequence: 9 givenname: Kenneth M. surname: Grigor fullname: Grigor, Kenneth M. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25918765$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22044434$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkt1u0zAUxwMaYh_wCsgSQhoXLXHipOkukNgEA1QJgVrBneXaJ62LY3e2s7Z3PALPyJNw0nadtCvITU6c3_mfD_9PkyPrLCQJoWmf4vNm0aesZD1G0x_9LKW0T9NiQPvrx8nJ4cfRXZwOy-PkNIRFmuJBWTxNjrMsZYzl7ORRde2cIjetMDpuyGquI_z59dvo2TyS6IUNrYc498IQDwFk1M4SV5OpEUqBJ7FtXOsDOb_-imnfR-PJt8vxa7LScU5gvQSvwUpQBGVm4GwgeFQ732g7I9I1SwMR7pUDEVYRN41C245QEH0bnCdNG6TpQNVKCASENxv8kq33nT7RllhYEdwSdrGDMdD2VgR9C4dupUDYX5BbnFaJ7SxCehcCibqBbfGlEXIXobxrGrB7ELsmUyw2b4T_ic09S57UwgR4vn-fJZMP78dXH3ujL9efrt6NepINKtoDNRwMqFSFzFMoqKBVwXKoM6UEUzIrK8EqKEVN2RDyAagMplVWM0XrXKZTIfOz5Hynu_TupoUQeaODBGOEBdcGTvH6qyJlGUP05QN0gZdjsTtO8yLP2bDMM6Re7Kl22oDiS69xpA2_8wQCr_aACFKYGl0gdbjniiGtBmWBXLXjtiv0UB8QmvLOpnzBOwfyzo28synf2pSvMfXtg1Sp43bP6Dlt_kNgpQ1s_rkwv_w82Yb5X94mDqY |
CODEN | BJINFO |
CitedBy_id | crossref_primary_10_3389_fonc_2022_788568 crossref_primary_10_1016_j_jsurg_2018_08_001 crossref_primary_10_1097_j_pbj_0000000000000179 crossref_primary_10_1111_iju_15480 crossref_primary_10_1177_2051415819890464 crossref_primary_10_1089_end_2015_0591 crossref_primary_10_3310_PLPU1526 crossref_primary_10_1007_s00092_016_0917_0 crossref_primary_10_1186_s13063_017_1843_5 crossref_primary_10_1016_j_eururo_2016_03_053 crossref_primary_10_1097_MOU_0000000000000751 crossref_primary_10_1016_j_ejso_2018_06_004 crossref_primary_10_4111_icu_2016_57_S1_S44 crossref_primary_10_1080_21681805_2019_1604568 crossref_primary_10_1007_s13193_022_01516_8 crossref_primary_10_3390_cancers12103063 crossref_primary_10_1016_j_euf_2023_07_002 crossref_primary_10_4111_kju_2015_56_8_553 crossref_primary_10_1016_j_urology_2015_04_015 crossref_primary_10_4111_kju_2015_56_11_749 crossref_primary_10_1002_cncr_29071 crossref_primary_10_1111_bju_12355 crossref_primary_10_1111_bju_12235 crossref_primary_10_3109_21681805_2014_1000963 crossref_primary_10_1111_bju_16433 crossref_primary_10_1016_j_juro_2016_03_151 crossref_primary_10_1111_j_1464_410X_2012_11011_4_x crossref_primary_10_1016_j_euo_2024_01_012 crossref_primary_10_1159_000528926 crossref_primary_10_1016_j_juro_2014_01_087 crossref_primary_10_1517_14712598_2013_824421 crossref_primary_10_2196_42254 crossref_primary_10_1016_j_eucr_2015_10_006 crossref_primary_10_1016_j_juro_2014_02_2573 crossref_primary_10_3390_cancers16193361 crossref_primary_10_48095_cccu2018034 crossref_primary_10_1097_MOU_0000000000000281 crossref_primary_10_1007_s00345_024_05342_1 crossref_primary_10_1186_s12894_023_01278_7 crossref_primary_10_4103_UROS_UROS_133_22 crossref_primary_10_1016_j_urolonc_2014_04_005 crossref_primary_10_1038_s41379_019_0403_9 crossref_primary_10_36290_uro_2017_004 crossref_primary_10_1016_j_euf_2021_07_011 crossref_primary_10_3109_21681805_2016_1163616 crossref_primary_10_1007_s11934_016_0579_1 crossref_primary_10_1097_PAP_0000000000000152 crossref_primary_10_3233_BLC_160076 crossref_primary_10_1016_j_urolonc_2023_08_004 crossref_primary_10_3390_cancers16101936 crossref_primary_10_1007_s11934_014_0450_1 crossref_primary_10_1016_j_eururo_2020_06_051 crossref_primary_10_1111_bju_15150 crossref_primary_10_1007_s00345_017_2077_6 crossref_primary_10_1016_j_acuro_2023_10_007 crossref_primary_10_3238_arztebl_m2021_0013 crossref_primary_10_1080_21681805_2022_2041086 crossref_primary_10_1586_era_12_87 crossref_primary_10_1080_21681805_2022_2119271 crossref_primary_10_1007_s00345_012_0967_1 crossref_primary_10_1038_s41585_024_00904_9 crossref_primary_10_1007_s00345_019_02734_6 crossref_primary_10_1002_bco2_365 crossref_primary_10_1016_j_eururo_2016_05_041 crossref_primary_10_1089_end_2015_1507 crossref_primary_10_1111_iju_14761 crossref_primary_10_1007_s00345_018_2602_2 crossref_primary_10_1016_j_juro_2017_04_077 crossref_primary_10_1016_j_eururo_2018_02_014 crossref_primary_10_1016_j_aju_2016_10_003 crossref_primary_10_1080_14737140_2018_1535314 crossref_primary_10_1016_j_acuroe_2023_12_007 crossref_primary_10_1016_j_eururo_2014_01_006 crossref_primary_10_1007_s00345_013_1035_1 crossref_primary_10_1007_s11934_024_01243_3 crossref_primary_10_1016_j_euf_2020_08_007 crossref_primary_10_1111_j_1464_410X_2012_11011_3_x crossref_primary_10_2147_RRU_S386026 crossref_primary_10_3390_life12050641 crossref_primary_10_1007_s13629_014_0110_8 crossref_primary_10_1016_j_eururo_2013_06_003 crossref_primary_10_1016_j_jfma_2021_01_012 crossref_primary_10_1016_j_urolonc_2021_05_036 crossref_primary_10_1111_ijcp_12075 crossref_primary_10_1177_0391560319899303 crossref_primary_10_1089_end_2020_0821 |
Cites_doi | 10.1097/01.ju.0000070437.14275.e0 10.1016/j.urology.2009.08.082 10.1016/j.urology.2005.08.066 10.1016/S1569-9056(08)60267-5 10.1097/01.ju.0000181811.61199.35 10.1016/j.eursup.2009.06.003 10.1016/S0022-5347(05)64273-5 10.1097/00005392-199907000-00018 10.1016/j.ucl.2005.02.002 10.1016/S0022-5347(05)64993-2 10.1016/S0022-5347(05)66532-9 10.1111/j.1464-410X.2006.06145.x 10.1016/S0302-2838(02)00068-4 10.1097/01.ju.0000158450.71497.ae 10.1016/S0022-5347(05)65969-1 10.1016/S0302-2838(01)00026-4 10.1016/S0090-4295(02)01920-9 10.1016/j.juro.2006.10.048 10.1016/S1569-9056(08)60433-9 10.1016/j.eururo.2009.05.047 10.1111/j.1464-410X.2008.07966.x 10.1097/01.ju.0000149163.08521.69 10.1097/01.ju.0000125486.92260.b2 |
ContentType | Journal Article |
Contributor | Bollina, Prasad McNeill, Alan Donat, Roland Riddick, Anthony |
Contributor_xml | – sequence: 1 givenname: Prasad surname: Bollina fullname: Bollina, Prasad – sequence: 2 givenname: Alan surname: McNeill fullname: McNeill, Alan – sequence: 3 givenname: Roland surname: Donat fullname: Donat, Roland – sequence: 4 givenname: Anthony surname: Riddick fullname: Riddick, Anthony |
Copyright | 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL 2015 INIST-CNRS 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL. |
Copyright_xml | – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL – notice: 2015 INIST-CNRS – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL. |
CorporateAuthor | for members of the Edinburgh Urological Cancer Group Edinburgh Urological Cancer Group |
CorporateAuthor_xml | – name: for members of the Edinburgh Urological Cancer Group – name: Edinburgh Urological Cancer Group |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8 |
DOI | 10.1111/j.1464-410X.2011.10571.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | Calcium & Calcified Tissue Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1464-410X |
EndPage | 1673 |
ExternalDocumentID | 2975457011 22044434 25918765 10_1111_j_1464_410X_2011_10571_x BJU10571 |
Genre | article Journal Article |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 23N 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8 |
ID | FETCH-LOGICAL-c4781-ed9771cd5c30e51a18543ef2dda4dc268a48e6af149e37ed2eb82f4d1f3c0bac3 |
IEDL.DBID | DR2 |
ISSN | 1464-4096 1464-410X |
IngestDate | Thu Sep 04 19:43:04 EDT 2025 Fri Jul 25 04:14:41 EDT 2025 Mon Jul 21 06:04:48 EDT 2025 Mon Jul 21 09:13:21 EDT 2025 Thu Apr 24 23:13:11 EDT 2025 Tue Jul 01 03:49:54 EDT 2025 Sun Sep 21 06:23:46 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Nephrology Relapse White light transurethral resection of bladder tumour Complete Time Transurethral route Urology Surgery Detrusor muscle Quality Validation Urinary system disease Surgical resection Urinary tract disease Malignant tumor Bladder cancer Bladder tumor Surgeon Recommendation recurrence Treatment Quality control Early Surgical approach Bladder disease Non muscle invasive bladder cancer Cancer |
Language | English |
License | CC BY 4.0 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4781-ed9771cd5c30e51a18543ef2dda4dc268a48e6af149e37ed2eb82f4d1f3c0bac3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1464-410X.2011.10571.x |
PMID | 22044434 |
PQID | 1353349632 |
PQPubID | 1026371 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1011850424 proquest_journals_1353349632 pubmed_primary_22044434 pascalfrancis_primary_25918765 crossref_primary_10_1111_j_1464_410X_2011_10571_x crossref_citationtrail_10_1111_j_1464_410X_2011_10571_x wiley_primary_10_1111_j_1464_410X_2011_10571_x_BJU10571 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2012 |
PublicationDateYYYYMMDD | 2012-06-01 |
PublicationDate_xml | – month: 06 year: 2012 text: June 2012 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: Edgecliff |
PublicationTitle | BJU international |
PublicationTitleAlternate | BJU Int |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Wiley-Blackwell Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley-Blackwell – name: Wiley Subscription Services, Inc |
References | 2001; 166 2001; 165 2009; 57 2010; 75 2005; 173 2005; 174 2002; 41 1991; 67 2010; 108 2002; 168 2007; 177 2004; 171 2002; 167 2005; 97 1999; 162 2008; 7 2009; 8 2003; 170 2005; 32 2002; 60 2008; 102 2005; 66 e_1_2_8_23_2 e_1_2_8_24_2 e_1_2_8_25_2 e_1_2_8_26_2 e_1_2_8_9_2 e_1_2_8_2_2 e_1_2_8_4_2 e_1_2_8_3_2 e_1_2_8_6_2 e_1_2_8_5_2 e_1_2_8_8_2 e_1_2_8_7_2 e_1_2_8_20_2 e_1_2_8_21_2 e_1_2_8_22_2 Anderson CH (e_1_2_8_27_2) 2010; 108 e_1_2_8_16_2 e_1_2_8_17_2 e_1_2_8_18_2 e_1_2_8_12_2 e_1_2_8_13_2 e_1_2_8_14_2 e_1_2_8_15_2 Koloszy Z (e_1_2_8_19_2) 1991; 67 e_1_2_8_10_2 e_1_2_8_11_2 22455408 - BJU Int. 2012 Apr;109(8):E27; author reply E27-8 |
References_xml | – volume: 168 start-page: 1964 year: 2002 end-page: 70 article-title: Intravesical bacillus Calmette‐Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta‐analysis of the published results of randomized clinical trials publication-title: J Urol – volume: 108 start-page: 6 issue: 1 year: 2010 article-title: RRFFC following PDD‐TURBT is better than even GQ‐WLTURBT – a prospective controlled study publication-title: BJU Int – volume: 173 start-page: 1108 year: 2005 end-page: 11 article-title: A surveillance schedule in G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years: based on a 25‐year prospective database publication-title: J Urol – volume: 41 start-page: 523 year: 2002 end-page: 31 article-title: Variability in the recurrence rate at first follow‐up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies publication-title: Eur Urol – volume: 67 start-page: 1761 year: 1991 end-page: 4 article-title: Histopathological ‘self control’ in TUR of bladder tumours publication-title: Br J Urol – volume: 7 start-page: 269 issue: 3 year: 2008 article-title: Completeness of the first resection of bladder tumour depending on the seniority of the surgeon publication-title: Eur Urol – volume: 97 start-page: 1194 year: 2005 end-page: 98 article-title: A re‐staging transurethral resection predicts early progression of superficial bladder cancer publication-title: BJU Int – volume: 165 start-page: 808 year: 2001 end-page: 10 article-title: Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early publication-title: J Urol – volume: 8 start-page: 542 year: 2009 end-page: 8 article-title: Transurethral resection of non‐muscle invasive bladder cancer publication-title: Eur Urol Suppl – volume: 57 start-page: 843 year: 2009 end-page: 9 article-title: Grigor KM and members of the Edinburgh Uro‐oncology group. Detrusor muscle in the first, apparently complete TURBT specimen is a surrogate marker of resection quality, predicts early recurrence and is dependent on operator experience publication-title: Eur Urol – volume: 41 start-page: 105 year: 2002 end-page: 12 article-title: Guidelines on bladder cancer publication-title: Eur Urol – volume: 166 start-page: 490 year: 2001 end-page: 3 article-title: Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy publication-title: J Urol – volume: 171 start-page: 2186 year: 2004 end-page: 90 article-title: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials publication-title: J Urol – volume: 174 start-page: 2260 year: 2005 end-page: 3 article-title: The actual incidence of bladder perforation following transurethral bladder surgery publication-title: J Urol – volume: 102 start-page: 1242 year: 2008 end-page: 6 article-title: Quality control in transurethral resection of bladder tumours publication-title: BJU Int – volume: 167 start-page: 2404 year: 2002 end-page: 7 article-title: Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling publication-title: J Urol – volume: 162 start-page: 74 year: 1999 end-page: 6 article-title: The value of a second transurethral resection in evaluating patients with bladder tumours publication-title: J Urol – volume: 7 start-page: 437 issue: 3 year: 2008 article-title: Dedicated teaching programs can improve the quality of TUR of non‐muscle invasive bladder tumour (NMIBT): experience of a single institution publication-title: Eur Urol – volume: 170 start-page: 433 year: 2003 end-page: 7 article-title: Effect of routine repeat transurethral resection for superficial bladder cancer: a long‐term observational study publication-title: J Urol – volume: 32 start-page: 133 year: 2005 end-page: 45 article-title: Optimal management of the T1G3 bladder cancer publication-title: Urol Clin North Am – volume: 75 start-page: 365 year: 2010 end-page: 8 article-title: Complete Transurethral Resection of Bladder Tumour’: are the guidelines being followed publication-title: Urology – volume: 60 start-page: 822 year: 2002 end-page: 5 article-title: Impact of a second transurethral resection on the staging of T1 bladder cancer publication-title: Urology – volume: 66 start-page: 108 issue: 6A year: 2005 end-page: 25 article-title: Management of stage T1 tumours of the bladder: international consensus panel publication-title: Urology – volume: 177 start-page: 867 year: 2007 end-page: 75 article-title: Pattern of recurrence changes in noninvasive bladder tumours observed during 2 decades publication-title: J Urol – volume: 173 start-page: 1908 year: 2005 end-page: 11 article-title: Does the management of bladder perforation during transurethral resection of superficial bladder tumours predispose to extravesical tumour recurrence? publication-title: J Urol – ident: e_1_2_8_2_2 – ident: e_1_2_8_7_2 doi: 10.1097/01.ju.0000070437.14275.e0 – ident: e_1_2_8_18_2 doi: 10.1016/j.urology.2009.08.082 – ident: e_1_2_8_22_2 doi: 10.1016/j.urology.2005.08.066 – ident: e_1_2_8_20_2 doi: 10.1016/S1569-9056(08)60267-5 – ident: e_1_2_8_24_2 doi: 10.1097/01.ju.0000181811.61199.35 – ident: e_1_2_8_3_2 doi: 10.1016/j.eursup.2009.06.003 – volume: 108 start-page: 6 issue: 1 year: 2010 ident: e_1_2_8_27_2 article-title: RRFFC following PDD‐TURBT is better than even GQ‐WLTURBT – a prospective controlled study publication-title: BJU Int – ident: e_1_2_8_12_2 doi: 10.1016/S0022-5347(05)64273-5 – ident: e_1_2_8_13_2 doi: 10.1097/00005392-199907000-00018 – ident: e_1_2_8_23_2 doi: 10.1016/j.ucl.2005.02.002 – ident: e_1_2_8_14_2 doi: 10.1016/S0022-5347(05)64993-2 – ident: e_1_2_8_8_2 doi: 10.1016/S0022-5347(05)66532-9 – ident: e_1_2_8_6_2 doi: 10.1111/j.1464-410X.2006.06145.x – ident: e_1_2_8_4_2 doi: 10.1016/S0302-2838(02)00068-4 – ident: e_1_2_8_25_2 doi: 10.1097/01.ju.0000158450.71497.ae – ident: e_1_2_8_16_2 doi: 10.1016/S0022-5347(05)65969-1 – ident: e_1_2_8_26_2 doi: 10.1016/S0302-2838(01)00026-4 – ident: e_1_2_8_15_2 doi: 10.1016/S0090-4295(02)01920-9 – volume: 67 start-page: 1761 year: 1991 ident: e_1_2_8_19_2 article-title: Histopathological ‘self control’ in TUR of bladder tumours publication-title: Br J Urol – ident: e_1_2_8_5_2 doi: 10.1016/j.juro.2006.10.048 – ident: e_1_2_8_21_2 doi: 10.1016/S1569-9056(08)60433-9 – ident: e_1_2_8_9_2 doi: 10.1016/j.eururo.2009.05.047 – ident: e_1_2_8_17_2 doi: 10.1111/j.1464-410X.2008.07966.x – ident: e_1_2_8_10_2 doi: 10.1097/01.ju.0000149163.08521.69 – ident: e_1_2_8_11_2 doi: 10.1097/01.ju.0000125486.92260.b2 – reference: 22455408 - BJU Int. 2012 Apr;109(8):E27; author reply E27-8 |
SSID | ssj0014665 |
Score | 2.3616998 |
Snippet | Study Type – Therapy (cohort)
Level of Evidence 2b
What's known on the subject? and What does the study add?
Apart from bladder tumour multiplicity, size,... Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size,... Study Type - Therapy (cohort) Level of Evidence2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size,... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1666 |
SubjectTerms | Aged Benchmarking Biological and medical sciences Bladder cancer Clinical Competence Cohort Studies Cystectomy Cystoscopy detrusor muscle Female Humans Light Male Medical sciences Middle Aged Multivariate analysis Neoplasm Recurrence, Local - pathology Neoplasm Staging Nephrology. Urinary tract diseases Predictive Value of Tests quality control recurrence transurethral resection of bladder tumour Tumors Tumors of the urinary system Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland |
Title | Good quality white‐light transurethral resection of bladder tumours (GQ‐WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non‐muscle‐invasive bladder cancer: validation across time and place and recommendation for benchmarking |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10571.x https://www.ncbi.nlm.nih.gov/pubmed/22044434 https://www.proquest.com/docview/1353349632 https://www.proquest.com/docview/1011850424 |
Volume | 109 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5QDwgJUd6klGqQOMDBUWyvY4cbBdqqokhUicjN2qcaNbaj2OF14ifwG_klzOw6rlL1UCFu63hnH87M7szuzDeMveQqSmKbCpTvUAYcLZRgZNM0GMRipEfaSO5yEZx8Gh5N-PE0mbb-TxQL4_EhugM3kgy3XpOAC1lfFnIe8HAw9UiclLE27JM-GcZDgtF_f9ohSWFVl1XSk6DavunUc2VDGzvVnYWo8aNZn-3iKnV0U7t129PBNjtfT8x7pZz3V43sq5-XMB__z8zvsbutFgtvPdvdZzdN-YDdOmnv6R_eyA6rSoMP2PwB3-iq4s-v33M6CICGdsfV0jRnS2yCop9caAVUFuSc1sElNKsCe6jh1eFnJPvycTw53R-_BjozBtNhM2uoKaYbxQYWPvwBt2FwPvJoCVy0XIMoNVSy8ckwQBsKNKmWUKxqHD1W1MjfNRjCesYn5SCrlIFZCWh0QFmVOApfGQuz8qsgn_9utIoEZ_kGUGZnPkMVCPeXQjMrjOvceb65Eh1AFIVpU1kBjhokdnZWCHdp8YhNDj6M3x0FbY6KQFGQbmA0KtCh0omKByYJBao_PDY20lpwraJhJnhmhsKiIWri1OjIyCyyXIc2VgMpVPyYbeE0zFMGVmR8ZAd6lKWSJ0pmqKxnmbEyHSrSknssXfNjrloAd8ojMs83DDmeE2PkxBi5Y4z8e4-FHeXCg5hcg2Zvg-U7QrSXQ9xCkx7bXctA3q57dU5ZVCgFQRz12IvuNa5YdA0lSlOtanIqxK9EV-499sTLzkXjEeEXxvgmdRJw7eHm-8cTV9z5Z8pn7Db-Hnk_wF22hbxonqPG2cg9t5b8BU6Rfa8 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5QkQAJ8SwQKGWQOMDBUWyvY4cbRbSlJJWoEpGbtS-rEbEdxQ6vEz-B38gvYWbXcZWqhwpx28g7611nZndm5_Ex9pKrIAqzWKB8-9LjaKF4gyyOvV4oBnqgjeQWi2B03D-c8KNpNG3ggCgXxtWHaC_cSDLsfk0CThfS56Wce9zvTV0pToKs9buoUF6z7jrSkE7aWlLY1-JKOhpU3DfDei4caeOsurUQFX62zOFdXKSQbuq39oDav8Pm66W5uJQv3VUtu-rnuaqP_2ntd9ntRpGFt47z7rGrprjPro8aV_2DK8lBWWpwOZs_4Bt5K_78-j2nuwCo6YBcLU19usQhKAHKZldAmYGc01a4hHqV4xsqeHXwCck-D8eTk73xa6BrYzBteWYNFaV1o-TAwmVA4EkMNkwejYGzkSsQhYZS1g4PA7ShXJNyCfmqwtljR40sXoGhcs_4S9mqVcrArAC0O6AoC5yF64yNWfFVUNh_O1tFsrN8Ayi2MwdSBcL-p1DPcmNfboPfbIvuIPLcNGhWgLMGiS87zYX1W2yzyf778btDr4Gp8BTl6XpGow7tKx2psGciX6AGxEOTBVoLrlXQTwRPTF9kaIuaMDY6MDIJMq79LFQ9KVT4kG3hMsxjBplI-CDr6UESSx4pmaC-niQmk3FfkaLcYfGaIVPV1HAnKJF5umHL8ZQYIyXGSC1jpN87zG8pF66OySVodjd4viVEk9nHUzTqsJ21EKTN1lelBKRCKARh0GEv2se4aZEnShSmXFUUV4hfibzuHfbICc_Z4AGVMAzxSWxF4NLTTfeOJrb55J8pn7Mbh-PRMB1-OP74lN3EPoELC9xhW8iX5hkqoLXctRvLX-Qrgc0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5QkSokxPsRKGWQOMDBUWyvY4cbBdJS2gqqRORmrfehRo3tKHZ4nfgJ_EZ-CTO7jqtUPVSI20beWe86Mzvf7M6DsRdcBlFoYoHy7WceRwvFG5g49nqhGKiB0hm3tQgOj_p7Y74_iSaN_xPFwrj8EO2BG0mG3a9JwOfKnBdy7nG_N3GZOKlird9FPHmN91FrEkA6blNJYV9bVtLRIG5f9-q5cKQ1VXVjLir8asaVu7gIj67DW6ufhrfY6Wplzi3ltLuss678eS7p4_9Z-m12s4Gx8Mbx3R12VRd32eZhc1F_70qyW5YKXMTmD_hGdxV_fv2e0UkA1KQelwtdnyxwCAp_srEVUBrIZrQRLqBe5viGCl7ufkayLwej8fHO6BXQoTHoNjmzgoqCulFuYO7iH1APg3WSR1PgbOQKRKGgzGpXDQOUpkiTcgH5ssLZY0eFDF6BpmTP-EvanFVSw7QAtDqgKAucheuMjWnxVZDTfztbSZKzeA0otFNXogqE_Uuhnubavty6vtkWnUDkuW5qWQHOGjJ82Uku7K3FfTYevh-93fOaIhWepChdTytE0L5UkQx7OvIF4h8eahMoJbiSQT8RPNF9YdAS1WGsVaCzJDBc-SaUvUzI8AHbwGXoRwyMSPjA9NQgiTMeySxBtJ4k2mRxXxJM7rB4xY-pbDK4UyGRWbpmyfGUGCMlxkgtY6TfO8xvKecui8klaLbXWL4lRIPZRx0addjWSgbSZuOrUiqjQjUIwqDDnrePccuieyhR6HJZkVchfiW6c--wh052zgYPKIFhiE9iKwGXnm66sz-2zcf_TPmMbX56N0wPPhx9fMKuY5fA-QRusQ1kS_0U0Wedbdtt5S8DOoB8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Good+quality+white-light+transurethral+resection+of+bladder+tumours+%28GQ-WLTURBT%29+with+experienced+surgeons+performing+complete+resections+and+obtaining+detrusor+muscle+reduces+early+recurrence+in+new+non-muscle-invasive+bladder+cancer%3A+validation+across+time+and+place+and+recommendation+for+benchmarking&rft.jtitle=BJU+international&rft.au=Mariappan%2C+Paramananthan&rft.au=Finney%2C+Steven+M&rft.au=Head%2C+Elizabeth&rft.au=Somani%2C+Bhaskar+K&rft.date=2012-06-01&rft.eissn=1464-410X&rft.volume=109&rft.issue=11&rft.spage=1666&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10571.x&rft_id=info%3Apmid%2F22044434&rft.externalDocID=22044434 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |